SG Americas Securities’s Alpine Immune Sciences Inc ALPN Stock Holding History

SG Americas Securities’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,686	Closed	-$106K	–	3429
2024 Q1	$106K	Buy	+2,686	New	+$79.3K	﹤0.01%	2522
2023 Q4	–	Sell	-9,927	Closed	-$114K	–	3523
2023 Q3	$114K	Buy	+9,927	New	+$122K	﹤0.01%	2705
2023 Q2	–	Sell	-11,927	Closed	-$92K	–	3373
2023 Q1	$92K	Buy	+11,927	New	+$95K	﹤0.01%	2942
2015 Q3	–	Sell	-5,000	Closed	-$303K	–	2803
2015 Q2	$303K	Buy	+5,000	New	+$298K	﹤0.01%	1765

SG Americas Securities's ALPN Position: Q2 2024 in Review

SG Americas Securities sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 2,686 shares — an estimated $106K sold.

SG Americas Securities first reported a position in ALPN in Q2 2015 and held it in 4 quarters. The position peaked at $303K in Q2 2015. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

SG Americas Securities reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
SG Americas Securities sold 2,686 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $106K.
SG Americas Securities first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 4 quarters.
SG Americas Securities's Alpine Immune Sciences Inc position peaked at $303K in Q2 2015.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on SG Americas Securities's 13F filing for Q2 2024, filed 12 Jul 2024.